Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.
2.

The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.

Giordano L, Gallo F, Petracci E, Chiorino G, Segnan N; Andromeda working group.

BMC Cancer. 2017 Nov 22;17(1):785. doi: 10.1186/s12885-017-3784-5.

3.

Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis.

Martínez-Alonso M, Carles-Lavila M, Pérez-Lacasta MJ, Pons-Rodríguez A, Garcia M, Rué M; InforMa Group.

BMJ Open. 2017 Oct 6;7(10):e016894. doi: 10.1136/bmjopen-2017-016894.

4.

Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.

Márquez-Rodas I, Pollán M, Escudero MJ, Ruiz A, Martín M, Santaballa A, Martínez Del Prado P, Batista N, Andrés R, Antón A, Llombart A, Fernandez Aramburu A, Adrover E, González S, Seguí MA, Calvo L, Lizón J, Rodríguez Lescure Á, Ramón Y Cajal T, Llort G, Jara C, Carrasco E, López-Tarruella S.

PLoS One. 2017 Oct 6;12(10):e0184181. doi: 10.1371/journal.pone.0184181. eCollection 2017.

5.

Current and Future Methods for Measuring Breast Density: A Brief Comparative Review.

Sak MA, Littrup PJ, Duric N, Mullooly M, Sherman ME, Gierach GL.

Breast Cancer Manag. 2015;4(4):209-221. doi: 10.2217/bmt.15.13. Epub 2015 Aug 28.

6.

Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide.

Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, López-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Schüz J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V.

PLoS Med. 2017 Jun 30;14(6):e1002335. doi: 10.1371/journal.pmed.1002335. eCollection 2017 Jun.

7.

Risk-based Breast Cancer Screening: Implications of Breast Density.

Lee CI, Chen LE, Elmore JG.

Med Clin North Am. 2017 Jul;101(4):725-741. doi: 10.1016/j.mcna.2017.03.005. Review.

PMID:
28577623
8.

Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening.

Román M, Quintana MJ, Ferrer J, Sala M, Castells X.

Br J Cancer. 2017 May 23;116(11):1480-1485. doi: 10.1038/bjc.2017.107. Epub 2017 Apr 20.

PMID:
28427083
9.

Quantification of masking risk in screening mammography with volumetric breast density maps.

Holland K, van Gils CH, Mann RM, Karssemeijer N.

Breast Cancer Res Treat. 2017 Apr;162(3):541-548. doi: 10.1007/s10549-017-4137-4. Epub 2017 Feb 4.

10.

Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems.

Burton A, Byrnes G, Stone J, Tamimi RM, Heine J, Vachon C, Ozmen V, Pereira A, Garmendia ML, Scott C, Hipwell JH, Dickens C, Schüz J, Aribal ME, Bertrand K, Kwong A, Giles GG, Hopper J, Pérez Gómez B, Pollán M, Teo SH, Mariapun S, Taib NA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Flugelman AA, Ursin G, Qureshi S, Ma H, Lee E, Sirous R, Sirous M, Lee JW, Kim J, Salem D, Kamal R, Hartman M, Miao H, Chia KS, Nagata C, Vinayak S, Ndumia R, van Gils CH, Wanders JO, Peplonska B, Bukowska A, Allen S, Vinnicombe S, Moss S, Chiarelli AM, Linton L, Maskarinec G, Yaffe MJ, Boyd NF, Dos-Santos-Silva I, McCormack VA.

Breast Cancer Res. 2016 Dec 19;18(1):130.

11.

Breast cancer risk prediction using a clinical risk model and polygenic risk score.

Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, Tice JA, Vachon CM, Cummings SR, Kerlikowske K, Ziv E.

Breast Cancer Res Treat. 2016 Oct;159(3):513-25. doi: 10.1007/s10549-016-3953-2. Epub 2016 Aug 26.

12.

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.

Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, Mandelblatt JS, Tosteson AN; Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network.

Ann Intern Med. 2016 Nov 15;165(10):700-712. doi: 10.7326/M16-0476. Epub 2016 Aug 23.

13.

The Utility of Endoscopic Biopsies in Patients with Normal Upper Endoscopy.

Teriaky A, AlNasser A, McLean C, Gregor J, Yan B.

Can J Gastroenterol Hepatol. 2016;2016:3026563. doi: 10.1155/2016/3026563. Epub 2016 Jul 10.

14.

Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.

Winkel RR, von Euler-Chelpin M, Nielsen M, Petersen K, Lillholm M, Nielsen MB, Lynge E, Uldall WY, Vejborg I.

BMC Cancer. 2016 Jul 7;16:414. doi: 10.1186/s12885-016-2450-7.

15.

Association between Breast Parenchymal Complexity and False-Positive Recall From Digital Mammography Versus Breast Tomosynthesis: Preliminary Investigation in the ACRIN PA 4006 Trial.

Ray S, Chen L, Keller BM, Chen J, Conant EF, Kontos D.

Acad Radiol. 2016 Aug;23(8):977-86. doi: 10.1016/j.acra.2016.02.019. Epub 2016 May 25.

16.

Developing a clinical utility framework to evaluate prediction models in radiogenomics.

Wu Y, Liu J, Del Rio AM, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES.

Proc SPIE Int Soc Opt Eng. 2015 Feb 21;9416. pii: 941617. Epub 2015 Mar 17.

17.

Breast cancer risk feedback to women in the UK NHS breast screening population.

Evans DG, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, Watterson D, Fox L, Sergeant JC, Ingham S, Harvie MN, Wilson M, Beetles U, Buchan I, Brentnall AR, French DP, Cuzick J, Howell A.

Br J Cancer. 2016 Apr 26;114(9):1045-52. doi: 10.1038/bjc.2016.56. Epub 2016 Mar 29.

18.

Risk of breast cancer after false-positive results in mammographic screening.

Román M, Castells X, Hofvind S, von Euler-Chelpin M.

Cancer Med. 2016 Jun;5(6):1298-306. doi: 10.1002/cam4.646. Epub 2016 Feb 25.

19.

Optimal breast cancer screening strategies for older women: current perspectives.

Braithwaite D, Demb J, Henderson LM.

Clin Interv Aging. 2016 Feb 3;11:111-25. doi: 10.2147/CIA.S65304. eCollection 2016. Review.

20.

Association Between Changes in Mammographic Image Features and Risk for Near-Term Breast Cancer Development.

Tan M, Zheng B, Leader JK, Gur D.

IEEE Trans Med Imaging. 2016 Jul;35(7):1719-28. doi: 10.1109/TMI.2016.2527619. Epub 2016 Feb 11.

Supplemental Content

Support Center